A patient with GOLD stage 3 COPD « cured » by one-way endobronchial valves

Eric Marchand, Jean Paul D’Odemont, Michael V. Dupont

Research output: Contribution to journalArticlepeer-review

19 Downloads (Pure)


Lung hyperinflation is a main determinant of dyspnoea in patients with chronic obstructive pulmonary disease (COPD). Surgical or bronchoscopic lung volume reduction are the most efficient therapeutic approaches for reducing hyperinflation in selected patients with emphysema. We here report the case of a 69-year old woman with COPD (GOLD stage 3-D) referred for lung volume reduction. She complained of persistent disabling dyspnoea despite appropriate therapy. Chest imaging showed marked emphysema heterogeneity as well as severe hyperinflation of the right lower lobe. She was deemed to be a good candidate for bronchoscopic treatment with one-way endobronchial valves. In the absence of interlobar collateral ventilation, 2 endobronchial valves were placed in the right lower lobe under general anaesthesia. The improvement observed 1 and 3 months after the procedure was such that the patient no longer met the pulmonary function criteria for COPD. The benefit persisted after 3 years.

Original languageEnglish
Article number65
Issue number3
Publication statusPublished - Mar 2019


  • COPD
  • Endobronchial valves
  • Lung hyperinflation
  • Lung volume reduction
  • Treatment

Cite this